IDCases . Cholangitis in three critically ill patients after a severe CoVID-19 infection

[tetano]

IDCases


. 2021 Aug 31;e01267.
doi: 10.1016/j.idcr.2021.e01267. Online ahead of print.
Cholangitis in three critically ill patients after a severe CoVID-19 infection


Cyrille Gourjault ¹ , Hassan Tarhini ¹ , Mayda Rahi ¹ , Michael Thy ¹ , Diane Le Pluart ¹ , Christophe Rioux ¹ , Marion Parisey ² , Sophie Ismael ¹ , Ali Al Rida Aidibi ³ , Valerie Paradis ^{4 5} , Jade Ghosn ^{1 6} , Yazdan Yazdanpanah ^{1 6} , François-Xavier Lescure ^{1 6} , Anne Gervais ¹



Affiliations

• PMID: 34485077
• PMCID: PMC8406543
• DOI: 10.1016/j.idcr.2021.e01267

Abstract

Coronavirus disease 2019 (CoVID-19) is a viral disease. Although the predominant presentation is respiratory disease, other manifestations such as gastrointestinal manifestations are commonly reported. Nevertheless, it has not been associated with chronic cholangitis or hepatic injury. In this study, we report three cases of severe CoVID-19 infection that required ICU admission, intubation, and sedation with ketamine. All three patients had abnormal liver function despite recovery and were diagnosed with cholangitis in the context of CoVID-19.

Keywords: CoVID-19; ICU; SARS-CoV-2; cholangitis; hepatobiliary diseases; liver transplantation.